Campagnoli C, Belforte L, Massara F, Peris C, Molinatti G M
J Endocrinol Invest. 1981 Jan-Mar;4(1):85-91. doi: 10.1007/BF03349421.
Clinical and/or biological improvement has been observed in 7 out of 17 patients with hyperprolactinemic amenorrhea followed for 6-15 months after the successful outcome of bromocriptine (Parlodel, Sandoz)- induced pregnancy. The ovulatory cycle was resumed in 2 out of these 7 patients (with subsequent spontaneous conception in 1); in 3 others the medroxyprogesterone acetate test became positive. In all cases, post-partum prolactin values were considerably reduced. The possible causes of this improvement are discussed, examining the present data and those in the literature. Regressive lesions, due for example to vascularization defects or hemorrhage occurring in the prolactin-secreting tissue, as a result of the hyperplastic stimulus of estrogens during pregnancy, are suggested as a possible explanation.
在17例高催乳素血症闭经患者中,有7例在溴隐亭(帕罗西汀,山德士公司生产)成功诱导妊娠后,随访6至15个月,观察到临床和/或生物学改善。这7例患者中有2例恢复了排卵周期(其中1例随后自然受孕);另外3例醋酸甲羟孕酮试验呈阳性。在所有病例中,产后催乳素值均显著降低。本文结合现有数据和文献中的数据,对这种改善的可能原因进行了讨论。例如,由于孕期雌激素的增生刺激,催乳素分泌组织中出现血管化缺陷或出血导致的退行性病变,被认为是一种可能的解释。